179 related articles for article (PubMed ID: 36327434)
1. Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
Rubenstein JH
Am J Gastroenterol; 2022 Nov; 117(11):1759-1761. PubMed ID: 36327434
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
Schlottmann F; Molena D; Patti MG
Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
[TBL] [Abstract][Full Text] [Related]
4. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
6. Screening for Barrett's esophagus.
Spechler SJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
[TBL] [Abstract][Full Text] [Related]
7. Reflux disease and Barrett's esophagus.
Qumseya BJ; Wolfsen CL; Wolfsen HC
Endoscopy; 2011 Nov; 43(11):962-5. PubMed ID: 22057759
[No Abstract] [Full Text] [Related]
8. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).
Hamel C; Ahmadzai N; Beck A; Thuku M; Skidmore B; Pussegoda K; Bjerre L; Chatterjee A; Dennis K; Ferri L; Maziak DE; Shea BJ; Hutton B; Little J; Moher D; Stevens A
Syst Rev; 2020 Jan; 9(1):20. PubMed ID: 31996261
[TBL] [Abstract][Full Text] [Related]
9. Endoscopy for Barrett's esophagus and esophageal adenocarcinoma.
Shaheen N
Am Fam Physician; 2004 May; 69(9):2060-1. PubMed ID: 15152951
[No Abstract] [Full Text] [Related]
10. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
[TBL] [Abstract][Full Text] [Related]
11. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?
Dellon ES; Shaheen NJ
J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837
[TBL] [Abstract][Full Text] [Related]
12. Screening for Barrett's esophagus.
DeVault KR
Am Fam Physician; 2004 May; 69(9):2061-3. PubMed ID: 15152952
[No Abstract] [Full Text] [Related]
13. Management strategies of Barrett's esophagus.
De Palma GD
World J Gastroenterol; 2012 Nov; 18(43):6216-25. PubMed ID: 23180941
[TBL] [Abstract][Full Text] [Related]
14. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
Hammad TA; Thrift AP; El-Serag HB; Husain NS
Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
Kamboj AK; Katzka DA; Iyer PG
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
[TBL] [Abstract][Full Text] [Related]
16. Barrett's Esophagus and the Prevention of Esophageal Adenocarcinoma.
Lightdale CJ
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):xiii-xiv. PubMed ID: 28577774
[No Abstract] [Full Text] [Related]
17. Screening for esophageal adenocarcinoma: an evidence-based approach.
Gerson LB; Triadafilopoulos G
Am J Med; 2002 Oct; 113(6):499-505. PubMed ID: 12427500
[TBL] [Abstract][Full Text] [Related]
18. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to reflux disease: newer approaches and strategies to columnar-lined esophagus.
Spechler SJ
J Gastroenterol; 2003 Mar; 38 Suppl 15():20-4. PubMed ID: 12698866
[No Abstract] [Full Text] [Related]
20. Barrett's esophagus.
Spechler SJ
Semin Gastrointest Dis; 1996 Apr; 7(2):51-60. PubMed ID: 8705259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]